

Special Issue on UDT in Opioid Therapies
Table of Contents
Articles
Richard A. DeVito, Jr, Paul Alexander Sloan, MD
|
|
Howard A. Heit, MD, FACP, FASAM, Douglas L. Gourlay, MD, MSc, FRCPC, FASAM
|
|
Anne Z. DePriest, PharmD, BCPS, David L. Black, PhD, D-ABFT, Timothy A. Robert, PhD, D-ABCC
|
|
Amadeo Pesce, PhD, Kenneth L. Kirsh, PhD, Angela Huskey, PharmD, CPE, Steven D. Passik, PhD, Catherine A. Hammett-Stabler, PhD
|
|
Gary M. Reisfield, MD, Bruce A. Goldberger, PhD, Roger L. Bertholf, PhD
|
|
Benjamin J. Morasco, PhD, Erin E. Krebs, MD, MPH, Renee Cavanagh, MS, Stephanie Hyde, MA, Aysha Crain, MSW, Steven K. Dobscha, MD
|
|
Kenneth L. Kirsh, PhD, Paul J. Christo, MD, MBA, Howard Heit, MD, Katherine Steffel, PharmD, Steven D. Passik, PhD
|
|
Kenneth L. Kirsh, PhD, Howard A. Heit, MD, Angela Huskey, PharmD, CPE, Jennifer Strickland, PharmD, BCPS, Kathleen Egan City, MA, BSN, RN, Steven D. Passik, PhD
|
|
Christine Moore, PhD, DSc, DABCC
|
|
Steven D. Passik, PhD, Kenneth L. Kirsh, PhD, Robert K. Twillman, PhD
|
|
Richard Payne, MD, Jeffrey L. Moe, PhD, Catherine Harvey Sevier, DrPH, David Sevier, MS, Michael Waitzkin, JD, LLM
|
|
Michael C. Barnes, Esq., Stacey L. Worthy, Esq
|
|